Ondine Biomedical Inc. (AIM:OBI)
London · Delayed Price · Currency is GBP · Price in GBX 13.75
0.00 (0.00%)
Jul 24, 2026, 3:44 PM GMT
Ondine Biomedical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.65 | 2.05 | 1.2 | 0.64 | 2.57 | |
Revenue Growth (YoY) | 29.14% | 70.32% | 88.56% | -75.17% | 43.44% |
Cost of Revenue | 1.03 | 0.73 | 0.5 | 0.35 | 1.32 |
Gross Profit | 1.61 | 1.32 | 0.7 | 0.29 | 1.25 |
Selling, General & Admin | 9.83 | 11.01 | 9.8 | 12.31 | 13.33 |
Depreciation & Amortization Expenses | 0.52 | 0.54 | 0.57 | 0.46 | 0.46 |
Research & Development | 21.23 | 9.22 | 5.14 | 6.28 | 4.98 |
Total Operating Expenses | 31.58 | 20.77 | 15.51 | 19.05 | 18.77 |
Operating Income | -29.97 | -19.44 | -14.81 | -18.76 | -17.52 |
Interest Income | 0.37 | 0.03 | 0.24 | 0.19 | - |
Interest Expense | -0.02 | -0.05 | -0.04 | -0.03 | -1.21 |
Other Non-Operating Income (Expense) | 0.11 | 0.37 | 0.19 | -0.77 | -31.35 |
Total Non-Operating Income (Expense) | 0.45 | 0.35 | 0.39 | -0.61 | -32.57 |
Pretax Income | -29.52 | -19.09 | -14.41 | -19.37 | -50.09 |
Net Income | -29.52 | -19.09 | -14.41 | -19.37 | -50.09 |
Net Income to Common | -29.52 | -19.1 | -14.41 | -19.37 | -50.09 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 465 | 275 | 197 | 195 | 80 |
Shares Outstanding (Diluted) | 465 | 275 | 197 | 195 | 80 |
Shares Change (YoY) | 69.37% | 39.31% | 1.30% | 144.34% | 12.69% |
EPS (Basic) | -0.06 | -0.07 | -0.07 | -0.10 | -0.63 |
EPS (Diluted) | -0.06 | -0.07 | -0.07 | -0.10 | -0.63 |
EPS Growth | - | - | - | - | - |
Free Cash Flow | -23.96 | -15.5 | -13.83 | -16.66 | -12.62 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Per Share | -0.05 | -0.06 | -0.07 | -0.09 | -0.16 |
Gross Margin | 60.92% | 64.47% | 58.44% | 44.98% | 48.81% |
Operating Margin | -1132.54% | -948.95% | -1230.67% | -2940.91% | -681.98% |
Profit Margin | -1115.53% | -931.82% | -1198.00% | -3036.36% | -1949.59% |
FCF Margin | -905.67% | -756.47% | -1149.63% | -2610.66% | -491.13% |
EBITDA | -29.38 | -18.88 | -14.22 | -18.27 | -17.01 |
EBITDA Margin | -1110.24% | -921.38% | -1181.88% | -2863.64% | -661.97% |
EBIT | -29.97 | -19.44 | -14.81 | -18.76 | -17.52 |
EBIT Margin | -1132.54% | -948.95% | -1230.67% | -2940.91% | -681.98% |